Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05243875 · ClinicalTrials.gov registry record · NA
Lupus Education Alliance Program
A NA study, sponsored by Tulane University.
- Terminated
- Registry status
- NA
- Development phase
- 274
- Enrollment target
NCT05243875: Clinical Trial NA study, sponsored by Tulane University.
NCT05243875 is a NA study that was terminated before completion, run by Tulane University. The registered enrollment target is 274 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05243875, a NA study, was terminated before completion, sponsored by Tulane University.
- TERMINATED
- Registry status
- NA
- Development phase
- 274 participants
- Enrollment target
Study Summary
Randomized controlled trial of a COVID-19 behavioral and educational intervention for people with systemic lupus erythematosus (SLE).
Primary Outcome
Participant-reported COVID testing
Interventions
- BEHAVIORAL LEAP Education + Navigation
- BEHAVIORAL LEAP Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 274 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2025-06-15 |
| Phase | NA |
Why NCT05243875 stopped before completion
NCT05243875 is an interventional study that assigns participants to a tested intervention. The registered 274 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 2 interventions - of which LEAP Education + Navigation is the first listed.
NCT05243875 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05243875 about?
NCT05243875 is a clinical study titled "Lupus Education Alliance Program". Randomized controlled trial of a COVID-19 behavioral and educational intervention for people with systemic lupus erythematosus (SLE).
What is the current status of trial NCT05243875?
This trial is currently terminated. It is a NA study. The enrollment target is 274 participants. The study started on 2023-11-01. Estimated completion is 2025-06-15.
What interventions are being tested in trial NCT05243875?
The interventions under investigation include: LEAP Education + Navigation (BEHAVIORAL), LEAP Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT05243875?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05243875's enrollment target sits among peer trials
274 385th of 2000 higher than 1,615 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03808922 · 274 participants · Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- NCT04573504 · 274 participants · Phase 4
Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair
- NCT05289557 · 274 participants · Phase 3
The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
- NCT05952583 · 274 participants
Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI